by Stacey Johnson | Jul 23, 2026
“Regulatory approval does not translate to dollars for a company, nor does it lead to patients being treated. Without reimbursement, all of the efforts of translation and development are lost.” My former colleague, Mark Curtis, wrote these words back when he blogged...
by Stacey Johnson | Jul 9, 2026
Celebrity health stories often dominate headlines, but their impact extends beyond entertainment news. High-profile diagnoses can raise awareness of rare diseases, increase participation in clinical trials, influence health policy, and accelerate investment in...
by Lyla El-Fayomi | Jun 24, 2026
Patients diagnosed with degenerative eye disorders, such as retinitis pigmentosa (RP) or choroideremia, face a gradual loss of light-sensing cells that eventually leads to blindness. Historically, most treatments could only aim to slow disease progression; however,...
by Michael May | Jun 9, 2026
Fifteen years ago, regenerative medicine in Canada stood at an inflection point. The science was world-class, the academic talent was undeniable, and the promise of cell and gene therapies was beginning to capture global attention. Yet there was a critical problem:...
by Ellie Kroeger | May 27, 2026
Humans have been obsessed with eternal youth for thousands of years. The search for elixirs, tonics, and the philosopher’s stone can be traced back to ancient civilizations. Only in the 1990s, however, did research show that lifespan may be modifiable. Pathways such...
by Krystal Jacques | Apr 28, 2026
Spontaneous neuronal regrowth and repair are not observed in adult spinal cords, making paralysis from spinal cord injury devastating and often permanent. In a new study, Professor Samuel Stupp’s research team at Northwestern University created human spinal cord...
Comments